GFR

$5.84

$

Greenfire Resources Ltd., together with its subsidiaries, engages in the development, exploration, and operation of oil and gas properties in the Athabasca oil sands region of Alberta. The company operates the Tier-1 oil sands assets located in Western Canada. It utilizes steam-assisted gravity drainage (SAGD) extraction technology, a thermal oil recovery process to recover bitumen. The company is headquartered in Calgary, Canada.

Next Earnings

2026-02-25

Beta

0.291

Average Volume

Market Cap

Last Dividend

CIK

0001966287

ISIN

CA39525U1075

CUSIP

CEO

Adam R. Waterous

Sector

Energy

Industry

Oil & Gas Exploration & Production

Full Time Employees

193

IPO Date

2021-12-13

Status

Active

Latest News

Title Headline Publisher Date
Greenfire Resources (NYSE:GFR) versus Clean Energy Pathways (OTCMKTS:CPWY) Head-To-Head Contrast Greenfire Resources (NYSE: GFR - Get Free Report) and Clean Energy Pathways (OTCMKTS:CPWY - Get Free Report) are both energy companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, earnings, profitability, institutional ownership and analyst recommendations. Risk and Volatility Greenfire Resources has a Defense World 2026-02-20 03:39:21
Head to Head Analysis: Greenfire Resources (NYSE:GFR) & Texas Pacific Land (NYSE:TPL) Texas Pacific Land (NYSE: TPL - Get Free Report) and Greenfire Resources (NYSE: GFR - Get Free Report) are both energy companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, dividends, profitability, risk and institutional ownership. Profitability This table compares Texas Pacific Land Defense World 2026-02-14 01:28:54
Transdermal GFR Article Recognized as One of Five 2025 Editors' Choice Articles by Journal of the American Society of Nephrology (JASN) NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that MediBeacon Inc. (“MediBeacon”), a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection, in which INNOVATE owns a 44.7% equity interest, announced that the peer-reviewed transdermal GFR measurement article published in the Journal of the American Society of Nephrology (JASN) has been recognized as one of five 2025 Editor's Choice articles.1 GlobeNewsWire 2026-02-10 16:05:00
Greenfire Resources Announces Closing of Rights Offering and Refinancing Initiatives Calgary, Alberta--(Newsfile Corp. - December 19, 2025) - Greenfire Resources Ltd. (NYSE: GFR) (TSX: GFR) ("Greenfire" or the "Company") is pleased to announce the successful completion of its previously announced refinancing initiatives (the "Refinancing Initiatives"). Newsfile Corp 2025-12-19 17:15:00
Greenfire Resources Announces Preliminary Results for Rights Offering Calgary, Alberta--(Newsfile Corp. - December 17, 2025) - Greenfire Resources Ltd. (NYSE: GFR) (TSX: GFR) ("Greenfire" or the "Company") today announced preliminary results of its C$300 million rights offering, which expired at 4:00 p.m. Newsfile Corp 2025-12-17 07:00:00

SEC Filings

Type Filing Date Accepted Date Link
SC 13G/A 2026-02-17 2026-02-17 View Filing
6-K 2025-12-23 2025-12-23 View Filing
6-K 2025-12-22 2025-12-22 View Filing
6-K 2025-12-17 2025-12-17 View Filing
SC 13D/A 2025-11-18 2025-11-18 View Filing
SC 13D/A 2025-11-12 2025-11-12 View Filing
SC 13G/A 2025-11-10 2025-11-10 View Filing
6-K 2025-11-06 2025-11-06 View Filing
FWP 2025-11-06 2025-11-06 View Filing
F-X 2025-11-06 2025-11-06 View Filing
F-10 2025-11-06 2025-11-06 View Filing
6-K 2025-11-04 2025-11-04 View Filing
SC 13G 2025-08-14 2025-08-14 View Filing
6-K 2025-08-07 2025-08-07 View Filing
SD 2025-05-29 2025-05-29 View Filing
6-K 2025-05-07 2025-05-07 View Filing
6-K 2025-05-07 2025-05-07 View Filing
6-K 2025-04-15 2025-04-15 View Filing
40-F 2025-03-20 2025-03-19 View Filing
6-K 2025-03-18 2025-03-18 View Filing
6-K 2025-02-21 2025-02-20 View Filing
6-K 2025-02-13 2025-02-12 View Filing
6-K 2025-01-03 2025-01-03 View Filing
RW 2025-01-03 2025-01-03 View Filing
6-K 2024-12-27 2024-12-27 View Filing
SC 13D/A 2024-12-27 2024-12-27 View Filing
SC 13D/A 2024-12-26 2024-12-26 View Filing
6-K 2024-12-26 2024-12-26 View Filing
8-A12B/A 2024-12-10 2024-12-10 View Filing
6-K 2024-12-09 2024-12-09 View Filing
6-K 2024-12-06 2024-12-06 View Filing
SC 13D/A 2024-11-21 2024-11-21 View Filing
6-K 2024-11-20 2024-11-20 View Filing
6-K 2024-11-18 2024-11-18 View Filing
6-K 2024-11-15 2024-11-14 View Filing
SC 13G/A 2024-11-14 2024-11-14 View Filing
SC 13D 2024-11-14 2024-11-14 View Filing
SC 13G/A 2024-11-13 2024-11-13 View Filing
SC 13G/A 2024-11-13 2024-11-13 View Filing
SC 13G/A 2024-11-13 2024-11-13 View Filing
CERT 2024-11-13 2024-11-13 View Filing
25-NSE 2024-11-13 2024-11-13 View Filing
8-A12B 2024-11-12 2024-11-12 View Filing
RW 2024-11-12 2024-11-12 View Filing
SC 13G/A 2024-11-12 2024-11-12 View Filing
6-K 2024-11-07 2024-11-07 View Filing
6-K 2024-11-04 2024-11-04 View Filing
6-K 2024-10-08 2024-10-07 View Filing
EFFECT 2024-10-02 2024-10-02 View Filing
6-K 2024-10-01 2024-10-01 View Filing
CERT 2024-09-24 2024-09-24 View Filing
6-K 2024-09-23 2024-09-23 View Filing
F-3 2024-09-20 2024-09-20 View Filing
8-A12B 2024-09-20 2024-09-20 View Filing
6-K 2024-09-19 2024-09-19 View Filing
SC 13G/A 2024-09-18 2024-09-18 View Filing
SC 13G/A 2024-09-18 2024-09-18 View Filing
SC 13G/A 2024-09-18 2024-09-18 View Filing
SC 13G/A 2024-09-18 2024-09-18 View Filing
SD 2024-09-16 2024-09-16 View Filing
424B3 2024-08-15 2024-08-15 View Filing
424B3 2024-08-15 2024-08-15 View Filing
6-K 2024-08-15 2024-08-14 View Filing
SC 13G/A 2024-07-16 2024-07-16 View Filing
SC 13G/A 2024-07-12 2024-07-12 View Filing
SC 13G/A 2024-07-11 2024-07-11 View Filing
6-K 2024-07-11 2024-07-10 View Filing
SC 13D/A 2024-07-05 2024-07-05 View Filing
SC 13G/A 2024-05-30 2024-05-30 View Filing
SC 13G/A 2024-05-30 2024-05-30 View Filing
6-K 2024-05-16 2024-05-16 View Filing
6-K 2024-05-14 2024-05-14 View Filing
424B3 2024-05-09 2024-05-09 View Filing
EFFECT 2024-05-08 2024-05-08 View Filing
POS AM 2024-04-30 2024-04-30 View Filing
6-K 2024-04-18 2024-04-18 View Filing
20-F/A 2024-04-12 2024-04-12 View Filing
6-K 2024-04-08 2024-04-08 View Filing
SC 13G 2024-04-04 2024-04-04 View Filing
6-K 2024-03-27 2024-03-26 View Filing
20-F 2024-03-27 2024-03-26 View Filing
6-K 2024-03-21 2024-03-21 View Filing
6-K 2024-03-19 2024-03-19 View Filing
6-K 2024-03-08 2024-03-08 View Filing

Algorithm Performance

Upgrade To Premium for Full Access
Algorithm Profit/Loss Profit Factor # Trades Sharpe Sortino Efficiency
Heikin Ashi Strategy 45.88% 0.89 6 0.77 1.24 70.41
Parabolic SAR Strategy 41.76% 0.95 39 0.57 0.33 66.29
Adaptive Wave 33.15% 1 1 0.85 1.17 17.08
xxxx xxxxxxx% xxxx xx xxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxxxx xxxxx
xxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxxx
xxxx xxxxxxx% xxxx xx xxxx xxxx xxxxx
xxxxxxxxxxxxxx xxxxx% xxx xx xxxx xxxx xxxxx
xxxxxxxxx xxxxxxx% xxx xx xxxx xxxx xxxx
xxxxxxxxx xxxxxxx% x x xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxx% xxxx xx xxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxx x xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxx x
xxxxxxxxxx xxxxxxx% xxxx xx xxxx xxx xxxxx
xxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxx x
xxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx x xxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxx xxxxxxx% xxxx x xxxx xxxx xxxxx
xxx xxxxxxx% xxxx xx xxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx x xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxx xxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% x xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx x xxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxx xxxxxx% xxx xx xxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxxx
xxx xxxxxxx% xxxx x xxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx x xxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxx xxxxxx% x xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxx xxxxxxx% xxxx x xxxx xxxx xxxxx
xxxxxxxxxxxx xxxxxx% xxxx x xxxx xx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxx xxxxxx% xxxx xx xxxx xxxx xxxx
xxxx xxxxxx% xxxx xx xxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxx x% x x x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxxxxxxxxxx x% x x x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx x% x x x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx x% x x x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxxx x% x x x x xxxxx
xxxxxxxxxxxxxxxx x% x x x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxxx x% x x x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx x x xxxxx
xxxxxxxxx xxxxxxxx% xxxx x xxxxx xxxx xxxxx
xxxx xxxxxxx% xxxx xx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxxx
xxxxxxxxx xxxxxxxx% x x xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxx
xxxxxxxxxxxx xxxxxxxx% x x xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx x
xxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx x
xxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% x x xxxxx xxxxx xxxx
xxxxxxxxxxxxx xxxxxxxx% xxxx x xxxxx xxxxx xxxx
xxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx x xxxxx xxxxx xxxxx
xxxxxxxxx xxxxxxxx% xxxx xx xxxx xxxxx xxxxx